If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
643.00    7.00 (1.10%)
Bid:
641.00
Ask:
642.00
Spread: 1.00 (0.156%)
Market Cap: £519.82m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

25 May 2006 07:00

Bloomsbury Publishing PLC25 May 2006 25 May 2006 Bloomsbury Acquires Theatre List Bloomsbury Publishing Plc, ("Bloomsbury"), the children's, adult and referencebook publisher, announced today that its subsidiary A & C Black has acquiredMethuen Drama Ltd for a total cash consideration of £2.35m. Methuen Drama Ltd has over 700 titles in print and the list includes plays bytop contemporary authors such as Caryl Churchill, Michael Frayn and David Mametas well as established classics by Bertolt Brecht, Oscar Wilde and Dario Fo.The list also includes practical books for students that cover voice training,directing and stage management, a number of more general titles, theatrebiographies, diaries and letters. The acquisition is complementary to a number of A&C Black's publishingactivities including its established practical theatre list and the New Mermaidsseries of plays. A&C Black has also recently reached agreement with the ShawFoundation to publish a number of Bernard Shaw's most famous plays and thesewill be rolled in to the Methuen Drama list. The Company plans to develop theMethuen Drama list across all of the English speaking markets, exploiting itmore fully in the trade and educational spheres. Nigel Newton, Chairman of Bloomsbury Publishing Plc, said: "Methuen Drama is a highly prestigious name and has a list of well known authorsand playwrights. We have the sales and marketing expertise to exploit its listfully in the trade and educational markets and will be looking to add bothpractical theatre titles and new works which will become the classic plays ofthe future." The Methuen general list will stay with the current management and will be soldunder the name Methuen Publishing Ltd. Peter Tummons, Managing Director of Methuen said: 'I am delighted that the drama list and the Methuen Drama name will go to suchan old established house as A&C Black, backed by the entrepreneurial spirit ofBloomsbury. I'm sure the list will prosper in such good hands'. ENDS For further information, please contact: Tim Spratt/Charles PalmerFinancial Dynamics 020 7831 3113 Sandy Karon, PA to the Chief ExecutiveBloomsbury Publishing Plc 020 7494 6015 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting
18th Jul 20237:00 amRNSAGM Trading Update
23rd Jun 20232:29 pmRNSAnnual Financial Report
2nd Jun 202311:50 amRNSDirector/PDMR Shareholding
1st Jun 20239:34 amRNSDirector Declaration
31st May 20232:04 pmRNSInvestor Presentation
31st May 20237:00 amRNSAudited Preliminary Results
16th May 20237:00 amRNSNotice of Capital Markets Event
2nd May 20232:43 pmRNSNotice of Results
12th Apr 20233:16 pmRNSHolding(s) in Company
11th Apr 202310:03 amRNSHolding(s) in Company
15th Mar 20237:00 amRNSTrading Update
1st Mar 20237:00 amRNSNotice of Trading Update
17th Feb 20232:09 pmRNSBLOCK LISTING SIX MONTHLY RETURN
11th Jan 20239:08 amRNSHolding(s) in Company
18th Nov 20222:29 pmRNSHolding(s) in Company
14th Nov 20225:16 pmRNSHolding(s) in Company
2nd Nov 20222:56 pmRNSDirector/PDMR Shareholding
1st Nov 20225:16 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSInvestor Presentation
27th Oct 20221:02 pmEQSBloomsbury Publishing pleased with 'surge in the numbers'
26th Oct 20227:00 amRNSUnaudited Interim Results
14th Oct 202212:41 pmRNSHolding(s) in Company
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Sep 202211:16 amRNSHolding(s) in Company
24th Aug 20225:01 pmRNSDirector/PDMR Shareholding
22nd Aug 20224:16 pmRNSDirector/PDMR Shareholding
17th Aug 20227:00 amRNSBlock Listing Six Monthly Return
10th Aug 20225:22 pmRNSDirector/PDMR Shareholding
29th Jul 20225:25 pmRNSHolding(s) in Company
20th Jul 20224:32 pmRNSResults of the 2022 Annual General Meeting
20th Jul 20227:00 amRNSAGM Trading Update
4th Jul 20223:52 pmRNSNotice of AGM Clarification
1st Jul 20227:00 amRNSBloomsbury wins Small Cap Award
28th Jun 20224:42 pmRNSAnnual Financial Report
15th Jun 20227:00 amRNSAudited Preliminary Results
25th May 202210:50 amRNSDirector Declaration
24th May 20227:00 amRNSNotice of Results
26th Apr 20224:22 pmRNSHolding(s) in Company
25th Apr 202211:52 amRNSHolding(s) in Company
22nd Apr 20222:12 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSTrading Update
11th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Feb 20222:50 pmRNSBlock Listing Six Monthly Return
26th Jan 20227:00 amRNSTrading Update
19th Jan 20225:45 pmRNSHolding(s) in Company
16th Dec 20217:00 amRNSAcquisition
27th Oct 20217:00 amRNSUnaudited Interim Results
27th Oct 20217:00 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.